Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Antineovascularized Medicines For The Treatment Of Eternal Macular Degeneration (Ranibizumab Or Aflibercept)

Valstybine ligoniu kasa prie Sveikatos apsaugos ministerijos Lithuania has Released a tender for Antineovascularized Medicines For The Treatment Of Eternal Macular Degeneration (Ranibizumab Or Aflibercept) in Pharmaceuticals. The tender was released on Mar 15, 2025.

Country - Lithuania

Summary - Antineovascularized Medicines For The Treatment Of Eternal Macular Degeneration (Ranibizumab Or Aflibercept)

Deadline - Apr 22, 2025

GT reference number - 105038774

Product classification - Ophthalmologicals

Organization Details:

  Address - Lithuania

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 105038774

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The Contracting Authority intends to acquire - Antineovascular medicines Ranibizumab and/or aflibecept. Requirements for the subject -matter of the procurement and the amount of medication purchased to determine in the SS Annex 2 "Techni cal Specification".local title:: Antineovaskuliarizuojantys vaistiniai preparatai amžinės geltonosios dėmės degeneracijai gydyti (Ranibizumab arba Aflibercept)Contract Duration: : 12 DAYContract Type: : Supplylocal description: : Perkančioji organizacija numato įsigyti – antineovaskuliarizuojančius vaistinius preparatus Ranibizumab ir/ar Aflibercept. Reikalavimai pirkimo objektui ir perkamas vaistų kiekis nustatyti SS 2 priede „Techni

Gt Ref Id - 105038774

Deadline - Apr 22, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database